{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:07:49Z","timestamp":1788908869845,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":97,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10440-4","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:26:12Z","timestamp":1780597572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peptide occupancy governs HLA-E checkpoint interactions enabling VISTA recognition of destabilized HLA-E conformers"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-6509","authenticated-orcid":false,"given":"Chelsae R.","family":"Watters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-6687","authenticated-orcid":false,"given":"Soroush","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donkor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Oter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Upchurch-Ange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gimlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niksa","family":"Kastrapeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-9319","authenticated-orcid":false,"given":"Jon","family":"Weidanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"10440_CR1","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.20020797","volume":"196","author":"J Micha\u00eblsson","year":"2002","unstructured":"Micha\u00eblsson, J. et al. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94\/NKG2A recognition. J. Exp. Med. 196, 1403\u20131414 (2002).","journal-title":"J. Exp. Med."},{"key":"10440_CR2","doi-asserted-by":"crossref","unstructured":"Hall T. Van, Oliveira, C. C., Joosten S. A. & Ottenhoff, T. H. M. The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress. Microbes Infect. 12, 910\u2013918 (2010).","DOI":"10.1016\/j.micinf.2010.07.011"},{"key":"10440_CR3","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1158\/1078-0432.CCR-19-2095","volume":"26","author":"L Borst","year":"2021","unstructured":"Borst, L., van der Burg, S. H. & van Hall, T. The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment. Clin. Cancer Res. 26, 5549\u20135556 (2021).","journal-title":"Clin. Cancer Res."},{"key":"10440_CR4","doi-asserted-by":"crossref","unstructured":"Middelburg, J. et al. The MHC-E peptide ligands for checkpoint CD94\/NKG2A are governed by inflammatory signals, whereas LILRB1\/2 receptors are peptide indifferent. Cell Rep. 42, 113516 (2023).","DOI":"10.1016\/j.celrep.2023.113516"},{"key":"10440_CR5","doi-asserted-by":"crossref","unstructured":"Lo Monaco, E. et al. HLA-E: strong association with \u03b22-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides. J. Immunol. 181, 5442\u20135450 (2008).","DOI":"10.4049\/jimmunol.181.8.5442"},{"key":"10440_CR6","doi-asserted-by":"crossref","unstructured":"Walters, L. C. et al. Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes. Cell Rep. 39, 110959 (2022).","DOI":"10.1016\/j.celrep.2022.110959"},{"key":"10440_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-022-05028-x","volume":"608","author":"J Shilts","year":"2022","unstructured":"Shilts, J. et al. A physical wiring diagram for the human immune system. Nature 608, 397\u2013404 (2022).","journal-title":"Nature"},{"key":"10440_CR8","doi-asserted-by":"crossref","unstructured":"Rogers, B. M. et al. Vista is an activating receptor in human monocytes. J. Exp. Med. 218, e20201601 (2021).","DOI":"10.1084\/jem.20201601"},{"key":"10440_CR9","doi-asserted-by":"crossref","unstructured":"Huang X., et al. VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy. J. Hematol. Oncol. 13, 83 (2020).","DOI":"10.1186\/s13045-020-00917-y"},{"key":"10440_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.790995","volume":"9","author":"S Schlichtner","year":"2022","unstructured":"Schlichtner, S. et al. Expression of the immune checkpoint protein VISTA is differentially regulated by the TGF-\u03b21 \u2013 Smad3 signaling pathway in rapidly proliferating human cells and T lymphocytes. Front Med 9, 1\u201310 (2022).","journal-title":"Front Med"},{"key":"10440_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-065X.1998.tb01192.x","volume":"163","author":"CA O\u2019Callaghan","year":"1998","unstructured":"O\u2019Callaghan, C. A. & Bell, J. I. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163, 129\u2013138 (1998).","journal-title":"Immunol. Rev."},{"key":"10440_CR12","first-page":"1","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang, X., Xiong, H. & Ning, Z. Implications of NKG2A in immunity and immune-mediated diseases. Front. Immunol. 13, 1\u201311 (2022).","journal-title":"Front. Immunol."},{"key":"10440_CR13","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1182\/blood-2006-06-030213","volume":"109","author":"S Coupel","year":"2007","unstructured":"Coupel, S. et al. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 109, 2806\u20132814 (2007).","journal-title":"Blood"},{"key":"10440_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aay0524","volume":"367","author":"MA ElTanbouly","year":"2020","unstructured":"ElTanbouly, M. A. et al. VISTA is a checkpoint regulator for na\u00efve T cell quiescence and peripheral tolerance. Science 367, 80 (2020).","journal-title":"Science"},{"key":"10440_CR15","doi-asserted-by":"crossref","unstructured":"Martin, A. S. et al. VISTA expression and patient selection for immune-based anticancer therapy. Front. Immunol. 14, 1086102 (2023).","DOI":"10.3389\/fimmu.2023.1086102"},{"key":"10440_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.adi7418","volume":"9","author":"HM Ta","year":"2024","unstructured":"Ta, H. M. et al. LRIG1 engages ligand VISTA and impairs tumor-specific CD8+ T cell responses. Sci. Immunol. 9, 1\u201334 (2024).","journal-title":"Sci. Immunol."},{"key":"10440_CR17","doi-asserted-by":"crossref","unstructured":"Johnston, R. J. et al. VISTA is an acidic pH-selective ligand for PSGL-1. Nature. 574, 565\u2013570 (2019).","DOI":"10.1038\/s41586-019-1674-5"},{"key":"10440_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imm.13001","volume":"156","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. VSIG-3 as a ligand of VISTA inhibits human T-cell function. Immunology 156, 74\u201385 (2019).","journal-title":"Immunology"},{"key":"10440_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2023.1225081","volume":"13","author":"RJ Noelle","year":"2023","unstructured":"Noelle, R. J. et al. Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights. Front. Oncol. 13, 1\u20139 (2023).","journal-title":"Front. Oncol."},{"key":"10440_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1329032","volume":"15","author":"S Brackenridge","year":"2024","unstructured":"Brackenridge, S., John, N., Fr\u00fch, K., Borrow, P. & McMichael, A. J. The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E. Front. Immunol. 15, 1\u201315 (2024).","journal-title":"Front. Immunol."},{"key":"10440_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"10440_CR22","unstructured":"\u00c1lvarez-Salmoral, D. et al. AlphaBridge: tools for the analysis of predicted macromolecular complexes. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2024.10.23.619601v3.abstract."},{"key":"10440_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/eji.202149745","volume":"52","author":"C Barber","year":"2022","unstructured":"Barber, C. et al. Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes using non-natural amino acids conserves native TCR recognition. Eur. J. Immunol. 52, 618\u2013632 (2022).","journal-title":"Eur. J. Immunol."},{"key":"10440_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1743362","volume":"17","author":"G Schaap","year":"2026","unstructured":"Schaap, G. et al. The murine MHC-E molecule Qa-1. Front. Immunol. 17, 1743362 (2026).","journal-title":"Front. Immunol."},{"key":"10440_CR25","doi-asserted-by":"crossref","unstructured":"Ljunggren, H. G. et al. Empty MHC class I molecules come out in the cold. Nature 346, 5719\u20135723 (1990).","DOI":"10.1038\/346476a0"},{"key":"10440_CR26","doi-asserted-by":"crossref","unstructured":"Anjanappa, R. et al. Structures of peptide-free and partially loaded of peptide selection. Nat. Commun. 11, 1314 (2020).","DOI":"10.1038\/s41467-020-14862-4"},{"key":"10440_CR27","doi-asserted-by":"crossref","unstructured":"Schoufour, T. A. W., Voogd L., Franken, K. L. M. C. & Ottenhoff, T. H. M. Conformation of HLA-E\/peptide complex guides interaction with two novel HLA-E receptors. PLoS ONE. 20, 1\u201316 (2025).","DOI":"10.1371\/journal.pone.0334543"},{"key":"10440_CR28","doi-asserted-by":"crossref","unstructured":"Ghaffari, S. et al. A Fully Human Pan VL9 HLAE TCRm antibody enables functional dissection of HLAE biology and checkpoint signaling. iScience 29, 115669 (2026).","DOI":"10.1016\/j.isci.2026.115669"},{"key":"10440_CR29","doi-asserted-by":"crossref","unstructured":"Huisman, B. D. et al. High-throughput characterization of HLA-E-presented CD94\/NKG2x ligands reveals peptides which modulate NK cell activation. Nat. Commun. 14, 4809 (2023).","DOI":"10.1038\/s41467-023-40220-1"},{"key":"10440_CR30","doi-asserted-by":"crossref","unstructured":"Kraemer, T., Blasczyk, R. & Bade-Doeding, C. HLA-E: a novel player for histocompatibility. J. Immunol. Res. 2014, 352160 (2014).","DOI":"10.1155\/2014\/352160"},{"key":"10440_CR31","doi-asserted-by":"crossref","unstructured":"Strong, R. K. et al. HLA-E allelic variants: correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278, 5082\u20135090 (2003).","DOI":"10.1074\/jbc.M208268200"},{"key":"10440_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pro.70201","volume":"34","author":"S Chakraborty","year":"2025","unstructured":"Chakraborty, S. et al. Unraveling antibody-induced mechanical stability of antigen: Insights from single-molecule studies. Protein Sci. 34, 1\u201311 (2025).","journal-title":"Protein Sci."},{"key":"10440_CR33","doi-asserted-by":"crossref","unstructured":"Smorodinsky-Atias, K. et al. On the same side: VISTA and its ligands interact in cis on the cell surface. Protein Sci. 35, 1\u201312, (2026).","DOI":"10.1002\/pro.70415"},{"key":"10440_CR34","doi-asserted-by":"crossref","unstructured":"Yasinska I. M. et al. Ligand-receptor interactions of galectin-9 and VISTA suppress human T lymphocyte cytotoxic activity. Front. Immunol. 11, 580557 (2020).","DOI":"10.3389\/fimmu.2020.580557"},{"key":"10440_CR35","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1021\/acs.jctc.4c00606","volume":"20","author":"R Calinsky","year":"2024","unstructured":"Calinsky, R. & Levy, Y. Histidine in proteins: pH-dependent interplay between \u03c0-\u03c0, cation-\u03c0, and CH-\u03c0 interactions. J. Chem. Theory Comput. 20, 6930\u20136945 (2024).","journal-title":"J. Chem. Theory Comput."},{"key":"10440_CR36","doi-asserted-by":"crossref","unstructured":"Nowak, E. C. et al. Immunoregulatory functions of VISTA. Immunol. Rev. 276, 66\u201379 (2017).","DOI":"10.1111\/imr.12525"},{"key":"10440_CR37","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Andoh, T. et al. A four amino acid intracellular motif of VISTA blocks growth receptor signaling in cancer cellsto induce tumor suppression. Cancer Res. 85, 3399\u20133415 (2025).","DOI":"10.1158\/0008-5472.CAN-24-4774"},{"key":"10440_CR38","doi-asserted-by":"crossref","unstructured":"He, W. et al. Intracellular trafficking of HLA-E and its regulation. J. Exp. Med. 220, e20221941 (2023).","DOI":"10.1084\/jem.20221941"},{"key":"10440_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.837097","volume":"13","author":"GA Noubissi Nzeteu","year":"2022","unstructured":"Noubissi Nzeteu, G. A. et al. Macrophage differentiation and polarization regulate the release of the immune checkpoint protein V-domain Ig suppressor of T cell activation. Front. Immunol. 13, 1\u201312 (2022).","journal-title":"Front. Immunol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10440-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:36:04Z","timestamp":1788906964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10440-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10440"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10440-4","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W. was a consultant for Boehringer-Ingelheim International GmbH at the time of this study. S. Ghaffari was a consultant for Resonant Sensors Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1183"}}